| Systematic (IUPAC) name | |
|---|---|
| (RS)-5-(2-{[3-(tert-butylamino)-2-hydroxypropyl]sulfanyl}- 1,3-thiazol-4-yl)thiophene-2-carboxamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Pharmacokinetic data | |
| Bioavailability | 2h |
| Half-life | 10h |
| Identifiers | |
| CAS number | 41287-43-8 |
| ATC code | None |
| PubChem | CID 2239 |
| ChemSpider | 2152 |
| UNII | 394E3P3B99 |
| KEGG | D07465 |
| ChEMBL | CHEMBL93298 |
| Chemical data | |
| Formula | C15H21N3O2S3 |
| Mol. mass | 371.54 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Arotinolol (INN, marketed under the tradename Almarl) is a medication in the class of mixed alpha/beta blockers. [1]
It is used in the treatment of high blood pressure.[2]
It has been proposed for use in treatment of essential tremor.[3]
Recommended dosage 10 - 30 mg
http://sdic.sookmyung.ac.kr/drug_monograph/view.asp?id=92
|
||||||||||||||||||||||
| This article about an amine is a stub. You can help Wikipedia by expanding it. |
| This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)